New study tracks daily life impact of breast cancer treatment

NCT ID NCT06931769

Recruiting now Knowledge-focused Sponsor: The Netherlands Cancer Institute Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows 100 people with stage III triple-negative breast cancer to see how standard treatments affect their quality of life. Participants fill out questionnaires about their well-being at nine time points and may give blood samples to track cancer DNA. The goal is to learn more about treatment effects, not to test a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm triple-negative breast carcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER

Contacts and locations

Locations

Amphia
NOT_YET_RECRUITING

Breda, Netherlands
Amsterdam University Medical Center
NOT_YET_RECRUITING

Amsterdam, Netherlands
ErasmusMC
RECRUITING

Rotterdam, Netherlands
Maastricht University Medical Center
RECRUITING

Maastricht, Netherlands
Medical spectrum Twente
RECRUITING

Enschede, Overijssel, 7500 KA, Netherlands
The Netherlands Cancer Institute
RECRUITING

Amsterdam, Netherlands
UMCG
RECRUITING

Groningen, 9713 GZ, Netherlands

More trials for these conditions

Other studies related to the condition(s) this trial covers.